1Todo S, Demetris AJ,Van Tiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology,1991,13: 619-626.
2O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B virus reinfection after orthotopic liver tranplantation: serological and clinical implications. J Hepatol, 1992,14:104-111.
3Perrillo R,Rakela J, Martin P, et al. Lamivudine for suppression and prevention of hepatitis B when given pre-post liver transplantation(OLT). Hepatology, 1997,26: 260A.
4Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against re-fection in liver transplantation for hepatitis B cirrhostis.Lancet, 1996,348:1212-1215.
5Han SH, Ofman J, Holt C, King K, Kunder G, Chen P, Dawson S, Goldstein L, Yersiz H, Farmer DG, Ghobrial RM, Busuttil RW, Martin P. An efficacy and cost-effectiveness analysis of combi nation hepatitis B immune globulin and lamivudine to prevent recrrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl 2000; 6:741-748
6Seehofer D, Rayes N,Steinmuller T, Muller AR, Settmacher U, Neuhaus R, Radke D, Berg T, Hopf U, Neuhaus P. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation. Live Transpl 2001; 7:976-982
7Segovia R, Sanchez-Fueyo A, Rimola A, Grande L, Bruguera M, Costa J, Soguero C, Uriz J. Evidence of serious graft damage induced by de novo hepatitis B Virus infection after livertransplantation. Liver Transpl 2001; 7:106-112
8Sanchez-Fueyo A, Rimola A, Grande L, Costa J, Mos A, NavasaM, Cirera I, Sanchez-Tapias JM, Rodes J. Hepatitis B immuno globulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000; 31:496-500
9Steinmuller T, Seehofer D, Rayes N, Muller AR, Settmacher U, Jonas S, Neuhaus R, Berg T, Hopf U, Neuhaus P. Increasing ap plicability of liver transplantation for patients with hepatitis B related liver disease. Hepatology 2002; 35:1528-1535
10Naoumov NV, Lopes AR, Burra P, Caccamo L, Temmolo RM, deMan RA, Basseudine M, O′Grady JG, Portmann BG, Anschuetz G, Barrett CA, Williams R, Atkins M. Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. J Hepatol 2001; 34:888-894
